India Diabetes Care Devices Market Outlook to 2016
Publisher Name » GlobalData
Published Date » 2010-04-30
No. Of Pages » 68
GlobalDatas medical equipment report offering, India Diabetes Care Devices Market Outlook to 2016 provides key market data on the India diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Market size and company share data for two diabetes care devices market categories Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
- Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the India diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the India diabetes care devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table Of Contents
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.1 What Is This Report About? 9
3 Diabetes Care Devices In India 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, India, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, India, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, India, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, India, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, India, Company Share (2008-2009) 20
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, India, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, India, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, India, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, India, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, India, Company Share (2008-2009) 20
4 Glucose Monitoring In India 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, India, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, India, Category Contribution (%), 2009 24
4.4 Glucose Monitoring Overall Revenue (2002-2016) 25
4.5 Glucose Monitoring Overall Volume (2002-2016) 27
4.6 Glucose Monitoring Average Price (2002-2016) 29
4.7 Glucose Monitoring Distribution Share (2008-2009) 30
4.8 Glucose Monitoring, India, Company Share (2008-2009) 31
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, India, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, India, Category Contribution (%), 2009 24
4.4 Glucose Monitoring Overall Revenue (2002-2016) 25
4.5 Glucose Monitoring Overall Volume (2002-2016) 27
4.6 Glucose Monitoring Average Price (2002-2016) 29
4.7 Glucose Monitoring Distribution Share (2008-2009) 30
4.8 Glucose Monitoring, India, Company Share (2008-2009) 31
5 Insulin Delivery In India 33
5.1 Insulin Delivery, Market Segmentation 33
5.2 Insulin Delivery Market, India, Revenue Mix ($m), 2009 34
5.3 Insulin Delivery Market, India, Category Contribution (%), 2009 35
5.4 Insulin Delivery Overall Revenue (2002-2016) 36
5.4.1 Insulin Pens Revenue (2002-2016) 38
5.5 Insulin Delivery Overall Volume (2002-2016) 40
5.5.1 Insulin Pens Volume (2002-2016) 42
5.6 Insulin Delivery Average Price (2002-2016) 44
5.7 Insulin Delivery Distribution Share (2008-2009) 45
5.8 Insulin Delivery, India, Company Share (2008-2009) 46
5.1 Insulin Delivery, Market Segmentation 33
5.2 Insulin Delivery Market, India, Revenue Mix ($m), 2009 34
5.3 Insulin Delivery Market, India, Category Contribution (%), 2009 35
5.4 Insulin Delivery Overall Revenue (2002-2016) 36
5.4.1 Insulin Pens Revenue (2002-2016) 38
5.5 Insulin Delivery Overall Volume (2002-2016) 40
5.5.1 Insulin Pens Volume (2002-2016) 42
5.6 Insulin Delivery Average Price (2002-2016) 44
5.7 Insulin Delivery Distribution Share (2008-2009) 45
5.8 Insulin Delivery, India, Company Share (2008-2009) 46
6 Overview of Key Companies in India Diabetes Care Devices Market 48
6.1 F. Hoffmann-La Roche Ltd. 48
6.1.1 Company Overview 48
6.1.2 Share in the India Diabetes Care Devices Market 48
6.2 LifeScan, Inc. 49
6.2.1 Company Overview 49
6.2.2 Share in the India Diabetes Care Devices Market 49
6.3 Novo Nordisk A/S 50
6.3.1 Company Overview 50
6.3.2 Share in the India Diabetes Care Devices Market 50
6.4 Sanofi-Aventis 51
6.4.1 Company Overview 51
6.4.2 Share in the India Diabetes Care Devices Market 51
6.5 Medtronic, Inc. 52
6.5.1 Company Overview 52
6.5.2 Share in the India Diabetes Care Devices Market 52
6.6 Eli Lilly and Company 53
6.6.1 Company Overview 53
6.6.2 Share in the India Diabetes Care Devices Market 53
6.7 Bayer HealthCare AG 54
6.7.1 Company Overview 54
6.7.2 Share in the India Diabetes Care Devices Market 54
6.8 Becton, Dickinson and Company 55
6.8.1 Company Overview 55
6.9 B. Braun Melsungen AG 55
6.9.1 Company Overview 55
6.10 Terumo Corporation 56
6.10.1 Company Overview 56
6.11 Smiths Medical 56
6.11.1 Company Overview 56
6.12 Hindustan Syringes & Medical Devices Ltd. 57
6.12.1 Company Overview 57
6.13 ARKRAY, Inc. 57
6.13.1 Company Overview 57
6.14 Apex Biotechnology Corp. 57
6.14.1 Company Overview 57
6.15 Animas Corporation 58
6.15.1 Company Overview 58
6.16 Abbott Laboratories 58
6.16.1 Company Overview 58
6.17 Carewell Biotech Pvt. Ltd 58
6.17.1 Company Overview 58
6.18 Mehar Healthcare Corporation 59
6.18.1 Company Overview 59
6.19 Piramal Healthcare Limited 59
6.19.1 Company Overview 59
6.1 F. Hoffmann-La Roche Ltd. 48
6.1.1 Company Overview 48
6.1.2 Share in the India Diabetes Care Devices Market 48
6.2 LifeScan, Inc. 49
6.2.1 Company Overview 49
6.2.2 Share in the India Diabetes Care Devices Market 49
6.3 Novo Nordisk A/S 50
6.3.1 Company Overview 50
6.3.2 Share in the India Diabetes Care Devices Market 50
6.4 Sanofi-Aventis 51
6.4.1 Company Overview 51
6.4.2 Share in the India Diabetes Care Devices Market 51
6.5 Medtronic, Inc. 52
6.5.1 Company Overview 52
6.5.2 Share in the India Diabetes Care Devices Market 52
6.6 Eli Lilly and Company 53
6.6.1 Company Overview 53
6.6.2 Share in the India Diabetes Care Devices Market 53
6.7 Bayer HealthCare AG 54
6.7.1 Company Overview 54
6.7.2 Share in the India Diabetes Care Devices Market 54
6.8 Becton, Dickinson and Company 55
6.8.1 Company Overview 55
6.9 B. Braun Melsungen AG 55
6.9.1 Company Overview 55
6.10 Terumo Corporation 56
6.10.1 Company Overview 56
6.11 Smiths Medical 56
6.11.1 Company Overview 56
6.12 Hindustan Syringes & Medical Devices Ltd. 57
6.12.1 Company Overview 57
6.13 ARKRAY, Inc. 57
6.13.1 Company Overview 57
6.14 Apex Biotechnology Corp. 57
6.14.1 Company Overview 57
6.15 Animas Corporation 58
6.15.1 Company Overview 58
6.16 Abbott Laboratories 58
6.16.1 Company Overview 58
6.17 Carewell Biotech Pvt. Ltd 58
6.17.1 Company Overview 58
6.18 Mehar Healthcare Corporation 59
6.18.1 Company Overview 59
6.19 Piramal Healthcare Limited 59
6.19.1 Company Overview 59
7 Diabetes Care Devices Market Pipeline Products 60
8 Recent Developments 61
8.1 Legal and Regulatory 61
8.1.1 Jun 07, 2009: Poly Medicure Announces Appeal Decision In Patent Litigation With B. Braun 61
8.2 Product News 61
8.2.1 Oct 07, 2009: Johnson & Johnson Medical India To Launch Insulin Pumps By Year End 2009 61
8.1 Legal and Regulatory 61
8.1.1 Jun 07, 2009: Poly Medicure Announces Appeal Decision In Patent Litigation With B. Braun 61
8.2 Product News 61
8.2.1 Oct 07, 2009: Johnson & Johnson Medical India To Launch Insulin Pumps By Year End 2009 61
9 Appendix 62
9.1 Definitions of Markets Covered in the Report 63
9.1.1 Diabetes Care Devices 63
9.2 Research Methodology 65
9.3 Secondary Research 66
9.4 Primary Research 66
9.5 Models 67
9.6 Forecasts 67
9.7 Expert Panels 67
9.8 Currency Conversion 68
9.9 Contact Us 68
9.10 Disclaimer 68
9.1 Definitions of Markets Covered in the Report 63
9.1.1 Diabetes Care Devices 63
9.2 Research Methodology 65
9.3 Secondary Research 66
9.4 Primary Research 66
9.5 Models 67
9.6 Forecasts 67
9.7 Expert Panels 67
9.8 Currency Conversion 68
9.9 Contact Us 68
9.10 Disclaimer 68
List of Tables
Table 1: Diabetes Care Devices, India, Overall Revenue ($m), 2002-2016 11
Table 2: Diabetes Care Devices Market, India, Category Contribution (%), 2009 13
Table 3: Diabetes Care Devices, India, Cross-Segment Analysis, 2002-2016 14
Table 4: Diabetes Care Devices, India, Overall Revenue ($m), Historic, 2002-2009 15
Table 5: Diabetes Care Devices, India, Overall Revenue ($m), Forecast, 2009-2016 16
Table 6: Diabetes Care Devices, India, Category Volume (Units), 2002-2016 17
Table 7: Diabetes Care Devices, India, Category Volume (Units), Historic, 2002-2009 18
Table 8: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2009-2016 19
Table 9: Diabetes Care Devices, India, Company Share by Revenue ($m), 2008-2009 21
Table 10: Glucose Monitoring Market, India, Category Contribution (%), 2009 24
Table 11: Glucose Monitoring, India, Revenue ($m) by Segment, Historic, 2002-2009 25
Table 12: Glucose Monitoring, India, Revenue ($m) by Segment, Forecast, 2009-2016 26
Table 13: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2002-2009 27
Table 14: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2009-2016 28
Table 15: Glucose Monitoring, India, Average Price ($), Historic, 2002-2009 29
Table 16: Glucose Monitoring, India, Average Price ($), Forecast, 2009-2016 29
Table 17: Glucose Monitoring, India, Distribution Share by Revenue ($m), 2008-2009 30
Table 18: Glucose Monitoring, India, Company Share by Revenue ($m), 2008-2009 32
Table 19: Insulin Delivery Market, India, Category Contribution (%), 2009 35
Table 20: Insulin Delivery, India, Revenue ($m) by Segment, Historic, 2002-2009 36
Table 21: Insulin Delivery, India, Revenue ($m) by Segment, Forecast, 2009-2016 37
Table 22: Insulin Pens, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Table 23: Insulin Pens, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 39
Table 24: Insulin Delivery, India, Volume (Units) by Segment, Historic, 2002-2009 40
Table 25: Insulin Delivery, India, Volume (Units) by Segment, Forecast, 2009-2016 41
Table 26: Insulin Pens, India, Volume (Units) by Sub-Segment, Historic, 2002-2009 42
Table 27: Insulin Pens, India, Volume (Units) by Sub-Segment, Forecast, 2009-2016 43
Table 28: Insulin Delivery, India, Average Price ($), Historic, 2002-2009 44
Table 29: Insulin Delivery, India, Average Price ($), Forecast, 2009-2016 44
Table 30: Insulin Delivery, India, Distribution Share by Revenue ($m), 2008-2009 45
Table 31: Insulin Delivery, India, Company Share by Revenue ($m), 2008-2009 47
Table 32: Diabetes Care Devices Pipeline Products 60
Table 33: USD to Local Currency, India, Average Actual Rate 2002-2009 68
List of Figures
List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, India, Overall Revenue ($m), 2002-2016 11
Figure 3: Diabetes Care Devices Market, India, Revenue Mix ($m), 2009 12
Figure 4: Diabetes Care Devices Market, India, Category Contribution (%), 2009 13
Figure 5: Diabetes Care Devices, India, Cross-Segment Analysis, 2002-2016 14
Figure 6: Diabetes Care Devices, India, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Diabetes Care Devices, India, Overall Revenue ($m), Forecast, 2009-2016 16
Figure 8: Diabetes Care Devices, India, Category Volume (Units), 2002-2016 17
Figure 9: Diabetes Care Devices, India, Category Volume (Units), Historic, 2002-2009 18
Figure 10: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2009-2016 19
Figure 11: Diabetes Care Devices, India, Company Share (%), 2009 20
Figure 12: Glucose Monitoring, Market Segmentation 22
Figure 13: Glucose Monitoring Market, India, Revenue Mix ($m), 2009 23
Figure 14: Glucose Monitoring Market, India, Category Contribution (%), 2009 24
Figure 15: Glucose Monitoring, India, Revenue ($m) by Segment, Historic, 2002-2009 25
Figure 16: Glucose Monitoring, India, Revenue ($m) by Segment, Forecast, 2009-2016 26
Figure 17: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2002-2009 27
Figure 18: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2009-2016 28
Figure 19: Glucose Monitoring, India, Company Share (%), 2009 31
Figure 20: Insulin Delivery, Market Segmentation 33
Figure 21: Insulin Delivery Market, India, Revenue Mix ($m), 2009 34
Figure 22: Insulin Delivery Market, India, Category Contribution (%), 2009 35
Figure 23: Insulin Delivery, India, Revenue ($m) by Segment, Historic, 2002-2009 36
Figure 24: Insulin Delivery, India, Revenue ($m) by Segment, Forecast, 2009-2016 37
Figure 25: Insulin Pens, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Figure 26: Insulin Pens, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 39
Figure 27: Insulin Delivery, India, Volume (Units) by Segment, Historic, 2002-2009 40
Figure 28: Insulin Delivery, India, Volume (Units) by Segment, Forecast, 2009-2016 41
Figure 29: Insulin Pens, India, Volume (Units) by Sub-Segment, Historic, 2002-2009 42
Figure 30: Insulin Pens, India, Volume (Units) by Sub-Segment, Forecast, 2009-2016 43
Figure 31: Insulin Delivery, India, Company Share (%), 2009 46
Figure 32: F. Hoffmann-La Roche Ltd, Company Share (%), India Diabetes Care Devices Market, 2009 48
Figure 33: LifeScan, Inc., Company Share (%), India Diabetes Care Devices Market, 2009 49
Figure 34: Novo Nordisk A/S, Company Share (%), India Diabetes Care Devices Market, 2009 50
Figure 35: Sanofi-Aventis, Company Share (%), India Diabetes Care Devices Market, 2009 51
Figure 36: Medtronic, Inc., Company Share (%), India Diabetes Care Devices Market, 2009 52
Figure 37: Eli Lilly and Company, Company Share (%), India Diabetes Care Devices Market, 2009 53
Figure 38: Bayer HealthCare AG, Company Share (%), India Diabetes Care Devices Market, 2009 54
Figure 39: GlobalData Methodology 65
Figure 2: Diabetes Care Devices, India, Overall Revenue ($m), 2002-2016 11
Figure 3: Diabetes Care Devices Market, India, Revenue Mix ($m), 2009 12
Figure 4: Diabetes Care Devices Market, India, Category Contribution (%), 2009 13
Figure 5: Diabetes Care Devices, India, Cross-Segment Analysis, 2002-2016 14
Figure 6: Diabetes Care Devices, India, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Diabetes Care Devices, India, Overall Revenue ($m), Forecast, 2009-2016 16
Figure 8: Diabetes Care Devices, India, Category Volume (Units), 2002-2016 17
Figure 9: Diabetes Care Devices, India, Category Volume (Units), Historic, 2002-2009 18
Figure 10: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2009-2016 19
Figure 11: Diabetes Care Devices, India, Company Share (%), 2009 20
Figure 12: Glucose Monitoring, Market Segmentation 22
Figure 13: Glucose Monitoring Market, India, Revenue Mix ($m), 2009 23
Figure 14: Glucose Monitoring Market, India, Category Contribution (%), 2009 24
Figure 15: Glucose Monitoring, India, Revenue ($m) by Segment, Historic, 2002-2009 25
Figure 16: Glucose Monitoring, India, Revenue ($m) by Segment, Forecast, 2009-2016 26
Figure 17: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2002-2009 27
Figure 18: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2009-2016 28
Figure 19: Glucose Monitoring, India, Company Share (%), 2009 31
Figure 20: Insulin Delivery, Market Segmentation 33
Figure 21: Insulin Delivery Market, India, Revenue Mix ($m), 2009 34
Figure 22: Insulin Delivery Market, India, Category Contribution (%), 2009 35
Figure 23: Insulin Delivery, India, Revenue ($m) by Segment, Historic, 2002-2009 36
Figure 24: Insulin Delivery, India, Revenue ($m) by Segment, Forecast, 2009-2016 37
Figure 25: Insulin Pens, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Figure 26: Insulin Pens, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 39
Figure 27: Insulin Delivery, India, Volume (Units) by Segment, Historic, 2002-2009 40
Figure 28: Insulin Delivery, India, Volume (Units) by Segment, Forecast, 2009-2016 41
Figure 29: Insulin Pens, India, Volume (Units) by Sub-Segment, Historic, 2002-2009 42
Figure 30: Insulin Pens, India, Volume (Units) by Sub-Segment, Forecast, 2009-2016 43
Figure 31: Insulin Delivery, India, Company Share (%), 2009 46
Figure 32: F. Hoffmann-La Roche Ltd, Company Share (%), India Diabetes Care Devices Market, 2009 48
Figure 33: LifeScan, Inc., Company Share (%), India Diabetes Care Devices Market, 2009 49
Figure 34: Novo Nordisk A/S, Company Share (%), India Diabetes Care Devices Market, 2009 50
Figure 35: Sanofi-Aventis, Company Share (%), India Diabetes Care Devices Market, 2009 51
Figure 36: Medtronic, Inc., Company Share (%), India Diabetes Care Devices Market, 2009 52
Figure 37: Eli Lilly and Company, Company Share (%), India Diabetes Care Devices Market, 2009 53
Figure 38: Bayer HealthCare AG, Company Share (%), India Diabetes Care Devices Market, 2009 54
Figure 39: GlobalData Methodology 65
Upcoming Reports:
|
Palm Methyl Ester Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Palm methyl ester is a base used for producing biodiesel. It is produced from palm oil in a chemical process is known as transesterification. Methanol acts as a catalyst to convert palm oil to methyl ester. Palm oil cannot be directly used as engine oil due to higher viscosity than that of petroleum products. It is first converted to smaller molecules of methyl ester before being used as a diesel fuel. Palm methyl ester is a ready substitute for diesel. It is successfully tested and used as fuel for power stations and passenger cars. Increasing use of this substitute...
|
|
Bioplastics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Bioplastics are a type of plastic manufactured from biomass sources such as vegetable oils and certain starches and are also called biobased plastic or biodegradable plastic. They are commonly used for insulation, as a packaging material, and in crockery and food packaging. Since bioplastics are plant based products, the consumption of petroleum for the production of plastic is expected to decrease by 10-15 percent by 2018. The bioplastic industry has high potential for growth if the focus is not just the replacement of current plastic applications but innovation of newer...
|
|
Network Outsourcing Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Increasing pressure on businesses to grow revenues by keeping the production cost low is driving the outsourcing market across the globe. Most leading manufacturers are opting for network outsourcing due to its numerous advantages over self manufacture of goods.
The outsourcing market is becoming widely popular and growing rapidly as most companies are feeling the need to outsource their jobs for saving production and service costs and managing their businesses intelligently.
Network outsourcing is helping to increase the network capacity to meet the...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- Global and China Piano Industry Report, 2012-2013
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
